Chengfeng Bi

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “miR-17~92 Promotes Progression of ABC-DLBCL Lymphoma via Regulation of Canonical NF-kB Signaling”.

miR-17~92 Promotes Progression of ABC-DLBCL Lymphoma via Regulation of Canonical NF-kB Signaling

Research Square(2021)10.21203/rs.3.rs-691597/v1

N/A

0DataRank · unranked

1 citations

Huaqing Wang, Xiaoyan Zhang, Chengfeng Bi, Timothy W. McKeithan, Xin Huang +6 more

High‐grade B‐cell lymphoma not otherwise specified, with diffuse large B‐cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics

American Journal of Hematology(2024)10.1002/ajh.27513

N/A

0DataRank · unranked

13 citations

Alyssa Bouska, Tyler A. Herek, Catalina Amador, Joo Y. Song, Alexander M. Xu +25 more

MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCL

Clinical Immunology(2024)10.1016/j.clim.2024.110297

N/A

0DataRank · unranked

4 citations

Xuan Zhang, Xin Huang, Javeed Iqbal, Timothy W. McKeithan, Wing C. Chan +5 more

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Nature Communications(2025)10.1038/s41467-025-64666-7

N/A

0DataRank · unranked

2 citations

Roshia Ali, Alyssa Bouska, Dylan T. Jochum, Meghana Kesireddy, Simeon Mahov +34 more